Pharmacokinetics of Standard- and Reduced-Dose Recombinant Human Soluble Thrombomodulin in Patients with Septic Disseminated Intravascular Coagulation during Continuous Hemodiafiltration

Frontiers in Medicine

Eizo Watanabe¹ 

关键词: coagulopathy;    acute kidney injury;    renal dysfunction;    renal replacement therapy;    sepsis;   

DOI  :  10.3389/fmed.2017.00015

学科分类：医学（综合）

来源: Frontiers

【 摘 要 】

IntroductionRecombinant human soluble thrombomodulin (rTM) is reportedly excreted by the kidneys; therefore, the recommended dose for patients with renal impairment is one-third of the standard dose. The aim of this study was to evaluate whether this reduced dose of rTM achieves effective drug concentrations that are comparable to those of the standard dose in treating sepsis-induced disseminated intravascular coagulation (DIC) during continuous hemodiafiltration (CHDF).

【 授权许可】

CC BY